Technological innovation and healthcare professionals' workloads: an ambiguous relationship.

Auteurs : de Pires DE, Bertoncini JH, Trindade Lde L, Matos E, de Azambuja E, Borges AM
Année : 2012
Journal : Rev Gaucha Enferm
Volume : 33(1)
Pages : 157-68

Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours.

Auteurs : Awada A, Hendlisz A, Christensen O, Lathia CD, Bartholomeus S, Lebrun F, de Valeriola D, Brendel E, Radtke M, Delaunoit T, Piccart-Gebhart M, Gil T
Année : 2012
Journal : Eur. J. Cancer
Volume : 48(4)
Pages : 465-74

Second primary cancers in head and neck cancer patients: a challenging entity.

Auteurs : de Castro G, Awada A
Année : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pages : 203-4

Clinical development of new formulations of cytotoxics in solid tumors.

Auteurs : Azim HA, Awada A
Année : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pages : 325-31

Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology.

Auteurs : Awada A, Vandone AM, Aftimos P
Année : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pages : 297-304

New therapies in HER2-positive breast cancer: a major step towards a cure of the disease?

Auteurs : Awada A, Bozovic-Spasojevic I, Chow L
Année : 2012
Journal : Cancer Treat Rev
Volume : 38(5)
Pages : 494-504

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer.

Auteurs : Schuler M, Awada A, Harter P, Canon JL, Possinger K, Schmidt M, De Grève J, Neven P, Dirix L, Jonat W, Beckmann MW, Schütte J, Fasching PA, Gottschalk N, Besse-Hammer T, Fleischer F, Wind S, Uttenreuther-Fischer M, Piccart-Gebhart M, Harbeck N
Année : 2012
Journal : Breast Cancer Res. Treat.
Volume : 134(3)
Pages : 1149-59

Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer.

Auteurs : Bergh J, Mariani G, Cardoso F, Liljegren A, Awada A, Viganò L, Huang X, Verkh L, Kern KA, Giorgetti C, Gianni L
Année : 2012
Journal : Breast
Volume : 21(4)
Pages : 507-13

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.

Auteurs : Leboulleux S, Bastholt L, Krause T, de la Fouchardiere C, Tennvall J, Awada A, Gómez JM, Bonichon F, Leenhardt L, Soufflet C, Licour M, Schlumberger MJ
Année : 2012
Journal : Lancet Oncol
Volume : 13(9)
Pages : 897-905

Non-HIV Kaposi's sarcoma: a review and therapeutic perspectives.

Auteurs : Akasbi Y, Awada A, Arifi S, Mellas N, El Mesbahi O
Année : 2012
Journal : Bull Cancer
Volume : 99(10)
Pages : 92-9

M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy.

Auteurs : Ameye L, Paesmans M, Thiel S, Jensenius JC, Aoun M
Année : 2012
Journal : Clin. Exp. Immunol.
Volume : 167(2)
Pages : 303-8

Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplasic syndrome: a bicentric study.

Auteurs : Vaes M, Hites M, Cotton F, Bourguignon AM, Csergo M, Rasson C, Ameye L, Bron D, Jacobs F, Aoun M
Année : 2012
Journal : Antimicrob. Agents Chemother.
Volume : 56(12))
Pages : 6298-303

Mastocytosis: revisited with new cytogenetic data.

Auteurs : Vaes M, Vereecken P, de Wind R, Andry G, Li R, Bron D
Année : 2012
Journal : Rev Med Brux
Volume : 33(1)
Pages : 12-21

Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes.

Auteurs : van Staveren WC, Beeckman S, Tomás G, Dom G, Hébrant A, Delys L, Vliem MJ, Trésallet C, Andry G, Franc B, Libert F, Dumont JE, Maenhaut C
Année : 2012
Journal : Exp. Cell Res.
Volume : 318(5)
Pages : 444-52

EORTC 24051: Unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.

Auteurs : Lalami Y, Specenier PM, Awada A, Lacombe D, Liberatoscioli C, Fortpied C, El-Hariry I, Bogaerts J, Andry G, Langendijk HJ, Vermorken JB
Année : 2012
Journal : Radiother Oncol
Volume : 105(2)
Pages : 238-40

Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.

Auteurs : Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA
Année : 2012
Journal : Ann Oncol
Volume : 23(10)
Pages : 2708-2714

Quality of work life in doctors working with cancer patients.

Auteurs : Bragard I, Dupuis G, Razavi D, Reynaert C, Etienne AM
Année : 2012
Journal : Occup Med (Lond)
Volume : 62(1)
Pages : 34-40

The biological features and prognosis of breast cancer diagnosed during pregnancy: A case-control study.

Auteurs : Azim HA, Botteri E, Renne G, Dell orto P, Rotmensz N, Gentilini O, Sangalli C, Pruneri G, Di Nubila B, Locatelli M, Sotiriou C, Piccart-Gebhart M, Goldhirsch A, Viale G, Peccatori F
Année : 2012
Journal : Acta oncol (Stockholm)
Volume : 51(5)
Pages : 653-61

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Auteurs : Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, Mcgale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart-Gebhart M, Pritchard K
Année : 2012
Journal : Lancet
Volume : 379(9814)
Pages : 432-44

Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.

Auteurs : Lagemaat MW, Zechmann CM, Fütterer JJ, Weiland E, Lu J, Villeirs GM, Holshouser BA, van Hecke P, Lemort M, Schlemmer HP, Barentsz JO, Roell SO, Heerschap A, Scheenen TW
Année : 2012
Journal : J Magn Reson Imaging
Volume : 35(1)
Pages : 166-73